DISLEP

This brand name is authorized in Ecuador, Malta, Mexico

Active ingredients

The drug DISLEP contains one active pharmaceutical ingredient (API):

1 Levosulpiride UNII JTG7R315LK - LEVOSULPIRIDE

Levosulpiride is a selective antagonist at dopamine (D) receptors. Levosulpiride exerts a regulation action both on the central and peripheral nervous circuits controlling the dynamics of digestive system. Read about Levosulpiride

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
DISLEP Solution for injection / infusion	Medicines Authority (MT)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
N05AL07	Levosulpiride	N Nervous system → N05 Psycholeptics → N05A Antipsychotics → N05AL Benzamides
Discover more medicines within N05AL07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	Identifier(s): 5796-MEE-1220
Country: MT	Medicines Authority	Identifier(s): MA130/00501
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 131M2005